<DOC>
	<DOCNO>NCT02913690</DOCNO>
	<brief_summary>This study aim determine tocotrienol rich fraction ( TRF ) supplementation improve marker inflammation , oxidative stress blood lipid Malaysian hemodialysis ( HD ) patient .</brief_summary>
	<brief_title>Palm Tocotrienols Chronic Hemodialysis ( Malaysia ) ( PATCH )</brief_title>
	<detailed_description>This study multi-centered , randomize , double blind , placebo-controlled trial total 400 HD patient ( 200 supplement ; 200 control ) recruit government private setting . Subjects randomize either intervention control group . The intervention group receive TRF ( 300 mg ) , daily 12 month control group receive placebo , daily 12 month . In addition , group receive standard dietary counseling ensure compliance medical nutrition therapy guideline dialysis patient . Patients consent first subject screen identification eligible subject . The screening involve basic anthropometry measure ( height , weight , BMI ) , routine biochemistry result obtain medical record , assessment nutritional status dietary evaluation . About 15ml pre-dialysis blood collect respective nurse additional laboratory parameter ( hsCRP , atherogenic profile inflammatory marker ) . Patients fulfill inclusion criterion randomize either control intervention group . During 12 month treatment period , patient control intervention group assess baseline 3-monthly interval laboratory result , medical condition , hospitalization , nutritional status , dietary intake compliance towards supplementation ( intervention group ) . A final measurement take 3 month study completion post follow assessment upon cessation supplementation . In , patient data generate 6 time point . ( A similar study , follow similar protocol use study design intervention recruit 400 patient total ( 200 group ) Michigan , USA ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Provided consent comply study protocol Undergoing HD treatment thriceweekly &gt; 3 month Adequately dialyze ( Kt/V &gt; 1.2 urea reduction ratio ( URR ) 65 % ) hsCRP level &lt; 20 mg/dL . Participated another clinical trial involve investigational product past 12 week precede enrolment . Planned kidney transplant study duration . Intake vitamin Econtaining supplement ( &gt; 60 IU/day ) 30 day precede enrolment . Intake antiinflammatory medication except aspirin &lt; 325 mg/day past 30 day precede enrollment . Female patient pregnant , lactate plan pregnancy course trial . Poor adherence HD medical treatment Patient temporary catheter dialysis access baseline , patient receive graft/fistula within 6month study period . History hospitalization ( &gt; 2 time within past 90 day one hospitalization within 30 day ) precede enrollment . Receiving nutritional support ( via enteral intravenous route ) . Diagnosed HIV/AIDS and/or antiHIV therapy Receiving active treatment cancer ( exclude basal cell carcinoma skin ) . Patients Hepatitis B C. Any significant disease disorder opinion respective nephrologist may affect end result study Patients know allergy towards fish .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>Tocotrienol</keyword>
	<keyword>Vitamin E</keyword>
</DOC>